Aβ40 promotes neuronal cell fate in neural progenitor cells

Cell Death and Differentiation

Volumn 16, Issue 3, 2009, Pages 386-394

  Chen, Y ^a,b   Dong, C ^b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; CASPASE 3; CELL MARKER; CELL PROTEIN; DNA; NEURON SPECIFIC NUCLEAR PROTEIN; PROTEIN TUJ1; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN (1 42); AMYLOID BETA-PROTEIN (1-42); BIOLOGICAL MARKER; PEPTIDE FRAGMENT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN NERVE CELL; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL FATE; CELL RENEWAL; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL CULTURE; CELL CYCLE; CELL LINEAGE; CELL PROLIFERATION; CYTOLOGY; HUMAN; METABOLISM; MOUSE; NERVE CELL; PHYSIOLOGY; STEM CELL;

AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; CASPASE 3; CELL CYCLE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; DNA FRAGMENTATION; ENZYME ACTIVATION; HUMANS; MICE; NEUROGENESIS; NEURONS; PEPTIDE FRAGMENTS; RATS; STEM CELLS;

EID: 60849095497     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2008.94     Document Type: Article

References (40)

1. Fryer JD, Holtzman DM. The bad seed in Alzheimer's disease. Neuron 2005; 47: 167-168.
2. Kim J, Onstead L, Randle S, Price R, Smithson L, Zwizinski C et al Abeta40 inhibits amyloid deposition in vivo. J Neurosci 2007; 27: 627-633.
3. Kumar-Singh S, Theuns J, Van Broeck B, Pirici D, Vennekens K, Corsmit E et al. Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Abeta42 and decreased Abeta40. Hum Mutat 2006; 27: 686-695.
4. Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, Wiltfang J et al Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J Neurochem 2006; 96: 732-742.
5. Shen J, Kelleher III RJ. The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci USA 2007; 104: 403-409.
6. Deng Y, Tarassishin L, Kallhoff V, Peethumnongsin E, Wu L, Li YM et al. Deletion of presenilin 1 hydrophilic loop sequence leads to impaired gamma-secretase activity and exacerbated amyloid pathology. J Neurosci 2006; 26: 3845-3854.
7. Atwood CS, Obrenovich ME, Liu T, Chan H, Perry G, Smith MA et al. Amyloid-beta: A chameleon walAing in two worlds: a review of the trophic and toxic properties of amyloid-beta. Brain Res Brain Res Rev 2003; 43: 1-16.
8. Jin K, Galvan V, Xie L, Mao XO, Gorostiza OF, Bredesen DE et al. Enhanced neurogenesis in Alzheimer's disease transgenic (PDGF-APPSw,Ind) mice. Proc Natl Acad Sci USA 2004; 101: 13363-13367.
9. Dong H, Goico B, Martin M, Csernansky CA, Bertchume A, Csernansky JG. Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress. Neuroscience 2004; 127: 601-609.
10. Donovan MH, Yazdani U, Norris RD, Games D, German DC, Eisch AJ. Decreased adult hippocampal neurogenesis in the PDAPP mouse model of Alzheimer's disease. J Comp Neurol 2006; 495: 70-83.
11. Zhang C, McNeil E, Dressler L, Siman R. Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease. Exp Neurol 2007; 204: 77-87.
12. Wen PH, Hof PR, Chen X, Gluck K, Austin G, Younkin SG et al. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice. Exp Neurol 2004; 188: 224-237.
13. Wang R, Dineley KT, Sweatt JD, Zheng H. Presenilin 1 familial Alzheimer's disease mutation leads to defective associative learning and impaired adult neurogenesis. Neuroscience 2004; 126: 305-312.
14. Chevallier NL, Soriano S, Kang DE, Masliah E, Hu G, Koo EH. Perturbed neurogenesis in the adult hippocampus associated with presenilin-1 A246E mutation. Am J Pathol 2005; 167: 151-159.
15. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC et al. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 2004; 101: 343-347.
16. Ziabreva I, Perry E, Perry R, Minger SL, Ekonomou A, Przyborski S et al. Altered neurogenesis in Alzheimer's disease. J Psychosom Res 2006; 61: 311-316.
17. Boekhoorn K, Joels M, Lucassen PJ. Increased proliferation reflects glial and vascular-associated changes, but not neurogenesis in the presenile Alzheimer hippocampus. Neurobiol Dis 2006; 24: 1-14.
18. Sugaya K. Possible use of autologous stem cell therapies for Alzheimer's disease. Curr Alzheimer Res 2005; 2: 367-376.
19. Peterson DA. Stem cells in brain plasticity and repair. Curr Opin Pharmacol 2002; 2: 34-42.
20. Filippov V, Kronenberg G, Pivneva T, Reuter K, Steiner B, Wang LP et al. Subpopulation of nestin-expressing progenitor cells in the adult murine hippocampus shows electrophysiological and morphological characteristics of astrocytes. Mol Cell Neurosci 2003; 23: 373-382.
21. Fukuda S, Kato F, Tozuka Y, Yamaguchi M, Miyamoto Y, Hisatsune T. Two distinct subpopulations of nestin-positive cells in adult mouse dentate gyrus. J Neurosci 2003; 23: 9357-9366.
22. Kuwabara T, Hsieh J, Nakashima K, Taira K, Gage FH. A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell 2004; 116: 779-793.
23. McConnell SK, Kaznowski CE. Cell cycle dependence of laminar determination in developing neocortex. Science 1991; 254: 282-285.
24. Desai AR, McConnell SK. Progressive restriction in fate potential by neural progenitors during cerebral cortical development. Development 2000; 127: 2863-2872.
25. Cameron HA, McKay RD. Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus. J Comp Neurol 2001; 435: 406-417.
26. Raponi E, Agenes F, Delphin C, Assard N, Baudier J, Legraverend C et al. S100B expression defines a state in which GFAP-expressing cells lose their neural stem cell potential and acquire a more mature developmental stage. Glia 2007; 55: 165-177.
27. Becker KA, Ghule PN, Therrien JA, Lian JB, Stein JL, van Wijnen AJ et al. Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase. J Cell Physiol 2006; 209: 883-893.
28. Iwasaki K, Sunderland T, Kusiak JW, Wolozin B. Changes in gene transcription during a beta-mediated cell death. Mol Psychiatry 1996; 1: 65-71.
29. LaFerla FM, Hall CK, Ngo L, Jay G. Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice. J Clin Invest 1996; 98: 1626-1632.
30. Zhu X, Mei M, Lee HG, Wang Y, Han J, Perry G et al. P38 activation mediates amyloid-beta cytotoxicity. Neurochem Res 2005; 30: 791-796.
31. Masliah E, Mallory M, Alford M, Tanaka S, Hansen LA. Caspase dependent DNA fragmentation might be associated with excitotoxicity in Alzheimer disease. J Neuropathol Exp Neurol 1998; 57: 1041-1052.
32. Jin K, Xie L, Mao XO, Greenberg DA. Alzheimer's disease drugs promote neurogenesis. Brain Res 2006; 1085: 183-188.
33. Chen Y, Liu W, Naumovski L, Neve RL. ASPP2 inhibits APP-BP1-mediated NEDD8 conjugation to cullin-1 and decreases APP-BP1-induced cell proliferation and neuronal apoptosis. J Neurochem 2003; 85: 801-809.
34. Lopez-Toledano MA, Shelanski ML. Neurogenic effect of beta-amyloid peptide in the development of neural stem cells. J Neurosci 2004; 24: 5439-5444.
35. Mazur-Kolecka B, Golabek A, Nowicki K, Flory M, Frackowiak J. Amyloid-beta impairs development of neuronal progenitor cells by oxidative mechanisms. Neurobiol Aging 2006; 27: 1181-1192.
36. Herrup K, Neve R, Ackerman SL, Copani A. Divide and die: Cell cycle events as triggers of nerve cell death. J Neurosci 2004; 24: 9232-9239.
37. Serra HG, Duvick L, Zu T, Carlson K, Stevens S, Jorgensen N et al. RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell 2006; 127: 697-708.
38. Bansal R, Warrington AE, Gard AL, Ranscht B, Pfeiffer SE. Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development. J Neurosci Res 1989; 24: 548-557.
39. Dahlgren KN, Manelli AM, Stine Jr WB, Baker LK, Krafft GA, LaDu MJ. Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability. J Biol Chem 2002; 277: 32046-32053.
40. Olive PL, Banath JP, Durand RE. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the 'comet' assay. Radiat Res 1990; 122: 86-94.